Compare eBay Inc (EBAY) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs IDEXX Laboratories, Inc. — how do they compare? eBay Inc trades at $102.5 (market cap $47.17B), while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: eBay Inc and IDEXX Laboratories, Inc. are close in size by market cap, and eBay Inc pays a 1.17% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| EBAY | IDXX | |
|---|---|---|
Market Cap | $47.17B | $46.22B |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $766.68 |
52-Week Low | $79.41 | $526.44 |
Enterprise Value | $51.00B | $47.12B |
Dividend Yield | 1.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $102.23, down 5.09% amid reports GameStop may abandon its $56 billion takeover bid in favor of a partnership. The stock shows bearish technical signals with support near $104, while fundamentals remain solid with Q2 2026 earnings beating estimates and an 18.57% net income margin. Revenue growth is projected to reach $12.0 billion in 2026, though cash flow turned negative in 2025.
The outlook is mixed: strong execution and a potential partnership or buyout offer present upside, but withdrawal of the bid and insider selling pose near-term risks. Analyst consensus is a $119.31 price target with a buy rating, but investors face volatility from deal uncertainty and competitive pressures in e-commerce.
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
